Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Roivant Sciences Ltd WT
(NQ:
ROIVW
)
N/A
UNCHANGED
Last Price
Updated: 3:45 PM EDT, Sep 1, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Roivant Sciences Ltd WT
< Previous
1
2
Next >
Covant Therapeutics Announces the Formation of its Scientific Advisory Board to Support Platform and Pipeline Advancement
March 07, 2023
From
Roivant Sciences
Via
GlobeNewswire
Roivant Sciences Announces Change to its Board of Directors
February 21, 2023
From
Roivant Sciences
Via
GlobeNewswire
Roivant Sciences Reports Financial Results for the Third Quarter Ended December 31, 2022 and Provides Business Update
February 13, 2023
From
Roivant Sciences
Via
GlobeNewswire
Roivant Sciences Announces Pricing of Upsized Public Offering of Common Shares
February 02, 2023
From
Roivant Sciences
Via
GlobeNewswire
Roivant Sciences Announces Proposed Public Offering of Common Shares
February 01, 2023
From
Roivant Sciences
Via
GlobeNewswire
Roivant to Report Financial Results for the Third Quarter Ended December 31, 2022 on Monday, February 13, 2023
January 30, 2023
From
Roivant Sciences
Via
GlobeNewswire
Roivant Announces Statistically Significant and Clinically Meaningful Results from the Induction Period of TUSCANY-2, a Large Global Phase 2b Study of Subcutaneous RVT-3101 for the Treatment of Ulcerative Colitis in Both the Overall and the Biomarker
January 04, 2023
From
Roivant Sciences
Via
GlobeNewswire
Roivant and Pfizer Form New Vant Company Focused on Developing TL1A Drug Candidate for Inflammatory and Fibrotic Diseases
December 01, 2022
From
Roivant Sciences
Via
GlobeNewswire
Roivant Sciences Reports Financial Results for the Second Quarter Ended September 30, 2022 and Provides Business Update
November 14, 2022
From
Roivant Sciences
Via
GlobeNewswire
Affivant to Present Data on AFVT-2101 at 37th Annual Meeting of SITC
November 10, 2022
From
Roivant Sciences
Via
GlobeNewswire
Roivant Sciences Announces Pricing of Primary and Secondary Public Equity Offering
November 08, 2022
From
Roivant Sciences
Via
GlobeNewswire
Roivant Sciences Announces Proposed Public Equity Offering
November 07, 2022
From
Roivant Sciences
Via
GlobeNewswire
Roivant Sciences to Report Financial Results for the Second Quarter Ended September 30, 2022 on Monday, November 14, 2022 and Present at Upcoming Conferences
October 18, 2022
From
Roivant Sciences
Via
GlobeNewswire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.